29
Jun

AMAG Pharmaceuticals has stepped in to buy Cord Blood Registry for $700 million, capturing about half of the privately stored cord blood units and taking a prominent position as supplier of stem cells to R&D groups.

…read more

Source: AMAG snags Cord Blood Registry for $700M

    

0 No comments